硝苯地平联合硫酸镁对孕妇妊娠期高血压及心、肾功能的影响

Effect of nifedipine combined with magnesium sulfate on pregnancy induced hypertension and cardiac as well as renal function in pregnant women

  • 摘要: 目的 探讨硝苯地平联合硫酸镁治疗妊娠期高血压的疗效,并观察对孕妇心、肾功能的影响。 方法 将本院妇产科收治的78例妊娠期高血压孕妇随机分为对照组(n=39)和观察组(n=39), 所有孕妇均给予镇静、利尿等基础治疗。对照组给予硫酸镁静脉滴注治疗,观察组在对照组基础上联合硝苯地平口服治疗。检测2组治疗前后收缩压(SBP)、舒张压(DBP)水平并评估临床疗效; 同时检测2组治疗前后左心室射血分数(LVEF)、尿素氮(BUN)、肌酐(SCr)等心、肾功能指标的变化。 结果 2组治疗后SBP、DBP水平均较治疗前显著下降(P<0.05), 观察组治疗后SBP、DBP水平显著低于对照组(P<0.05)。观察组临床总有效率为97.44%, 高于对照组的79.49%, 差异有统计学意义(P<0.05)。对照组治疗前后LVEF比较无显著差异(P>0.05), 而BUN、SCr水平显著下降,差异有统计学意义(P<0.05), 观察组治疗后LVEF升高,BUN、SCr水平下降,差异有统计学意义(P<0.05), 观察组治疗后上述心、肾功能指标改善程度均优于对照组,差异有统计学意义(P<0.05)。 结论 硝苯地平联合硫酸镁能有效减轻妊娠期高血压孕妇的高血压症状、体征,增强临床疗效,同时有效改善心、肾功能,对保护母胎健康和改善妊娠结局有重要意义。

     

    Abstract: Objective To investigate the effect of nifedipine combined with magnesium sulfate in the treatment of pregnancy induced hypertension, and to observe its impact on cardiac and renal function. Methods A total of 78 pregnant women with hypertension during pregnancy were randomly divided into control group(n=39)and observation group(n=39), and all pregnant women were given sedation, diuresis and other basic treatments. The control group was given magnesium sulfate intravenous drip treatment, while the observation group was additionally given oral administration of nifedipine on the basis of the control group. Systolic blood pressure(SBP)and diastolic blood pressure(DBP)were measured before and after treatment, and the clinical effect was evaluated. At the same time, the changes of left ventricular ejection fraction(LVEF), urea nitrogen(BUN)and creatinine(SCr)were measured before and after treatment. Results The levels of SBP and DBP in the two groups were significantly lower than those treatment before(P<0.05), and was lower in the observation group than the control group(P<0.05). The total effective rate of the observation group was 97.44%, which was higher than 79.49% in the control group(P<0.05). There was no significant difference in LVEF before and after treatment in the control group(P>0.05), while levels of BUN and SCr were decreased(P<0.05). The observation group had significant increase in LVEF, and significant decrease in BUN, SCr after treatment(P<0.05). The heart and kidney function indicators above in the observation group were better than that in the control group(P<0.05). Conclusion Nifedipine combined with magnesium sulfate can effectively relieve the symptoms and signs of pregnant women with pregnancy induced hypertension, increase the clinical efficacy, and improve the - heart and kidney function. It is of great significance to protect the health of mother and fetus and improve the pregnancy outcomes.

     

/

返回文章
返回